Efung Capital
倚锋资本
Efung CapitalFund
倚锋资本
渲染中…
Mentioned in 4 articles
Coverage
Andon Therapeutics Raises Over 400 Million Yuan in Series C Funding to Accelerate Phase III Clinical Trials for Revolutionary Pan-Anemia Drug
Focused on R&D of novel drugs for kidney diseases, pan-anemia conditions, and cancer.
高榕创投·Securing Hundreds of Millions of Yuan in Pre-A Funding, How Westlake Omics Builds the AlphaFold of Proteomics | Gaorong "Future"
Deciphering the mathematical laws of the microscopic protein world to enable proteomics-based precision medicine.
高榕创投·Gaorong Monthly · December | Gaorong Ventures and Its Frontier Tech / Consumer / Healthcare / Enterprise Service Portfolio Companies Win Multiple Annual Awards
Its technological and innovative capabilities have won recognition.
高榕创投·Hangzhou Andao Pharma Closes $50 Million Series B to Advance Drug Development for Kidney Disease and Cancer
Addressing the enormous unmet clinical needs in nephrology and oncology.
高榕创投·
